{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:54:45Z","timestamp":1773939285897,"version":"3.50.1"},"reference-count":34,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"unspecified","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI179874"],"award-info":[{"award-number":["R01AI179874"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,4]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Respiratory syncytial virus (RSV) is a leading cause of hospitalisation in infants worldwide. New immunoprophylactic products, including long-acting monoclonal antibodies and maternal vaccines, have demonstrated high efficacy in prelicensure clinical trials. Understanding how these interventions perform outside controlled trials, and how viral evolution or host factors influence protection, is essential for sustaining confidence in RSV prevention programmes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will conduct a 5-year, test-negative case\u2013control study among infants \u226412 months of age who present with acute respiratory illness (ARI) within a large healthcare delivery network serving a demographically diverse population. Cases will be infants testing positive for RSV by PCR, and controls will be RSV-negative infants meeting the same ARI criteria. Data will be obtained from electronic health records, structured caregiver surveys and state immunization registries to ensure accurate classification of exposures and covariates. Vaccine effectiveness will be estimated using multivariable logistic regression controlling for potential confounding. RSV-positive specimens will undergo full-genome sequencing to identify variant lineages and potential immune-escape mutations. A subset of participants will provide acute and convalescent blood samples for single-cell immune profiling to define innate and adaptive responses associated with breakthrough infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study protocol has been approved by the Yale Human Investigation Committee (HIC #2000036550). Written informed consent will be obtained from all parents or legal guardians prior to participation. Study findings will be disseminated through peer-reviewed publications, scientific meetings and public repositories, with fully de-identified participant data to protect privacy and confidentiality. Viral genomic data will be shared in accordance with the National Institutes of Health Genomic Data Sharing Policy, and analytical code will be made publicly available to ensure reproducibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06172660\">NCT06172660<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-114524","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:35:41Z","timestamp":1773934541000},"page":"e114524","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world effectiveness of perinatal RSV immunoprophylaxis: protocol for a test-negative case\u2013control study"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06172660","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06172660","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9461-7172","authenticated-orcid":false,"given":"Camila","family":"Aparicio Llorente","sequence":"first","affiliation":[{"name":"Yale School of Medicine Department of Pediatrics, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aanchal","family":"Wats","sequence":"additional","affiliation":[{"name":"Yale School of Medicine Department of Pediatrics, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara L","family":"Araujo","sequence":"additional","affiliation":[{"name":"Yale School of Medicine Department of Pediatrics, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Moniz Ganem","sequence":"additional","affiliation":[{"name":"Yale School of Medicine Department of Pediatrics, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela O","family":"Oliva","sequence":"additional","affiliation":[{"name":"Yale School of Medicine Department of Pediatrics, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanmeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Yale School of Public Health Department of Epidemiology of Microbial Diseases, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina N","family":"Brodsky","sequence":"additional","affiliation":[{"name":"Yale School of Medicine Department of Pediatrics, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie L","family":"Lucas","sequence":"additional","affiliation":[{"name":"Yale School of Medicine Department of Immunobiology, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L","family":"Aronson","sequence":"additional","affiliation":[{"name":"Yale School of Medicine Department of Pediatrics, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan D","family":"Grubaugh","sequence":"additional","affiliation":[{"name":"Yale School of Public Health Department of Epidemiology of Microbial Diseases, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallery","family":"Breban","sequence":"additional","affiliation":[{"name":"Yale School of Public Health Department of Epidemiology of Microbial Diseases, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Redmond","sequence":"additional","affiliation":[{"name":"Yale School of Public Health Department of Epidemiology of Microbial Diseases, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene D","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Yale School of Medicine Department of Pediatrics, New Haven, Connecticut, USA"},{"name":"Yale School of Public Health Department of Epidemiology of Microbial Diseases, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M","family":"Niccolai","sequence":"additional","affiliation":[{"name":"Yale School of Public Health Department of Epidemiology of Microbial Diseases, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M","family":"Weinberger","sequence":"additional","affiliation":[{"name":"Yale School of Public Health Department of Epidemiology of Microbial Diseases, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1897-6581","authenticated-orcid":false,"given":"Carlos R","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Yale School of Medicine Department of Pediatrics, New Haven, Connecticut, USA"},{"name":"Yale School of Public Health Department of Biostatistics, New Haven, Connecticut, USA"},{"name":"Yale School of Medicine Department of Biomedical Informatics and Data Science, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2026031908352786000_16.3.e114524.1","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1093\/cid\/ciab528","article-title":"Global Respiratory Syncytial Virus-Related Infant Community Deaths","volume":"73","author":"Mazur","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026031908352786000_16.3.e114524.2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac120"},{"key":"2026031908352786000_16.3.e114524.3","unstructured":"USFaD A . FDA approves new drug to prevent rsv in babies and toddlers. 2023."},{"key":"2026031908352786000_16.3.e114524.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913556"},{"key":"2026031908352786000_16.3.e114524.5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","article-title":"Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials","volume":"7","author":"Sim\u00f5es","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"2026031908352786000_16.3.e114524.6","first-page":"181","article-title":"Nirsevimab: First Approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs (Abingdon Engl)"},{"key":"2026031908352786000_16.3.e114524.7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.15585\/mmwr.mm7432a3","article-title":"Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus\u2013Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2025","volume":"74","author":"Moulia","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026031908352786000_16.3.e114524.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2106062"},{"key":"2026031908352786000_16.3.e114524.9","unstructured":"USFaDA . FDA approves first vaccine for pregnant individuals to prevent rsv in infants. 2023."},{"key":"2026031908352786000_16.3.e114524.10","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piu058"},{"key":"2026031908352786000_16.3.e114524.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa951"},{"key":"2026031908352786000_16.3.e114524.12","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/jcm.25.8.1535-1539.1987","article-title":"Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections","volume":"25","author":"Mufson","year":"1987","journal-title":"J Clin Microbiol"},{"key":"2026031908352786000_16.3.e114524.13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy256"},{"key":"2026031908352786000_16.3.e114524.14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(24)00570-X","article-title":"Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study","volume":"25","author":"Fourati","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026031908352786000_16.3.e114524.15","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1093\/jpids\/piae027","article-title":"A Historical Perspective on Respiratory Syncytial Virus Prevention: A Journey Spanning Over Half a Century From the Setback of an Inactive Vaccine Candidate to the Success of Passive Immunization Strategy","volume":"13","author":"Noor","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2026031908352786000_16.3.e114524.16","doi-asserted-by":"crossref","first-page":"111737","DOI":"10.1016\/j.jclinepi.2025.111737","article-title":"Application of methodological strategies to address unmeasured confounding in real-world vaccine safety and effectiveness study: a systematic review","volume":"181","author":"Guo","year":"2025","journal-title":"J Clin Epidemiol"},{"key":"2026031908352786000_16.3.e114524.17","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kww064"},{"key":"2026031908352786000_16.3.e114524.18","unstructured":"Echelon Insights . Middle America Project, 2022. Available: https:\/\/echeloninsights.com\/map\/"},{"key":"2026031908352786000_16.3.e114524.19","unstructured":"Fitch ME . New haven county is now middle america, according to study. Inside Investigator; 2022."},{"key":"2026031908352786000_16.3.e114524.20","unstructured":"CDC . Nasal mid-turbinate (nmt) specimen collection steps. 2024."},{"key":"2026031908352786000_16.3.e114524.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-05175-4","article-title":"Global molecular diversity of RSV - the \u201cINFORM RSV\u201d study","volume":"20","author":"Langedijk","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2026031908352786000_16.3.e114524.22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41551-018-0194-1","article-title":"Microneedle-based device for the one-step painless collection of capillary blood samples","volume":"2","author":"Blicharz","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"2026031908352786000_16.3.e114524.23","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202300607","article-title":"Capillary blood self-collection for high-throughput proteomics","volume":"24","author":"El-Sabawi","year":"2024","journal-title":"Proteomics"},{"key":"2026031908352786000_16.3.e114524.24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr0942","article-title":"A single-cell atlas of circulating immune cells over the first 2 months of age in extremely premature infants","volume":"17","author":"Olaloye","year":"2025","journal-title":"Sci Transl Med"},{"key":"2026031908352786000_16.3.e114524.25","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7309a4"},{"key":"2026031908352786000_16.3.e114524.26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu327"},{"key":"2026031908352786000_16.3.e114524.27","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000109248.32907.1d"},{"key":"2026031908352786000_16.3.e114524.28","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.0380","article-title":"Estimated Effectiveness of Nirsevimab Against Respiratory Syncytial Virus","volume":"8","author":"Xu","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026031908352786000_16.3.e114524.29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2147\/CLEP.S378039","article-title":"Bayesian Model Averaging to Account for Model Uncertainty in Estimates of a Vaccine\u2019s Effectiveness","volume":"14","author":"Oliveira","year":"2022","journal-title":"Clin Epidemiol"},{"key":"2026031908352786000_16.3.e114524.30","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"2026031908352786000_16.3.e114524.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043093","article-title":"Effectiveness of HPV vaccine by age at vaccination and number of doses: protocol for a population-based matched case-control study","volume":"11","author":"Oliveira","year":"2021","journal-title":"BMJ Open"},{"key":"2026031908352786000_16.3.e114524.32","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2159"},{"key":"2026031908352786000_16.3.e114524.33","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/oxfordjournals.aje.a117730","article-title":"Case-cohort analysis of case-coverage studies of vaccine effectiveness","volume":"142","author":"Moulton","year":"1995","journal-title":"Am J Epidemiol"},{"key":"2026031908352786000_16.3.e114524.34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530290060038"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-114524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:35:45Z","timestamp":1773934545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-114524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,19]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2025-114524"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-114524","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}